BRG1-dependent chromatin remodeling at the promoters of lysosome-localized ABC transporters confers multidrug insensitivity in paclitaxel-resistant non-small cell lung cancer cells

被引：0
|
作者：
Gronkowska, Karolina [1 ]
Robaszkiewicz, Agnieszka [1 ]
机构：
[1] Univ Lodz, Dept Gen Biophys, Lodz, Poland
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P13.033.C
引用
收藏
页码：535 / 535
页数：1
相关论文
共 12 条
  • [1] Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer
    Fukuoka, J
    Fujii, T
    Shih, JH
    Dracheva, T
    Meerzaman, D
    Player, A
    Hong, K
    Settnek, S
    Gupta, A
    Buetow, K
    Hewitt, S
    Travis, WD
    Jen, J
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4314 - 4324
  • [2] Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer
    Farong Zang
    Yuanquan Rao
    Xinhai Zhu
    Zhibing Wu
    Hao Jiang
    Molecular Medicine, 2020, 26
  • [3] Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer
    Zang, Farong
    Rao, Yuanquan
    Zhu, Xinhai
    Wu, Zhibing
    Jiang, Hao
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [4] Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro
    Liu, Yanguo
    Xia, Handai
    Wang, Yawei
    Han, Wenfei
    Qin, Jing
    Gao, Wenjuan
    Qu, Xun
    Wang, Xiuwen
    THORACIC CANCER, 2021, 12 (22) : 3053 - 3061
  • [5] Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
    Tan, Tiantian
    Feng, Yuxin
    Wang, Weimin
    Wang, Rongrong
    Yin, Liyan
    Zeng, Yiying
    Zeng, Zhaowu
    Xie, Tian
    CANCER NANOTECHNOLOGY, 2023, 14 (01)
  • [6] Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer
    Tiantian Tan
    Yuxin Feng
    Weimin Wang
    Rongrong Wang
    Liyan Yin
    Yiying Zeng
    Zhaowu Zeng
    Tian Xie
    Cancer Nanotechnology, 2023, 14
  • [7] Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells
    Huaping Huang
    Tangying Li
    Mingjing Chen
    Feng Liu
    Haifeng Wu
    Jie Wang
    Jialiang Chen
    Xi Li
    Cellular & Molecular Biology Letters, 2018, 23
  • [8] Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells
    Huang, Huaping
    Li, Tangying
    Chen, Mingjing
    Liu, Feng
    Wu, Haifeng
    Wang, Jie
    Chen, Jialiang
    Li, Xi
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2018, 23
  • [9] Inhibition of epigenetic modifiers in non-small lung cancer cell lines with loss of function mutations in SWI/SNF chromatin remodeling genes: a tool for selective radiosensitization of BRG1 mutant NSCLC cell lines
    Zernickel, E.
    Sak, A.
    Niedermaier, B.
    Groneberg, M.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S169 - S170
  • [10] Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway
    Li, Chenchen
    Zhao, Xia
    Yang, Yang
    Liu, Siwen
    Liu, Yun
    Li, Xiaoyou
    MEDICAL SCIENCE MONITOR, 2018, 24 : 2750 - 2757
12